2012-09-17 06:01:15 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Markets Direct's, 'Premature Ejaculation - Pipeline Review, H2 2012', provides an overview of the Premature Ejaculation therapeutic pipeline. This report provides information on the therapeutic development for Premature Ejaculation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Premature Ejaculation. 'Premature Ejaculation - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/463724_premature_ejaculation_pipeline_review ..


Note*: Certain sections in the report may be removed or altered

based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Premature Ejaculation.
* A review of the Premature Ejaculation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Premature Ejaculation pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Premature Ejaculation.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Premature Ejaculation pipeline depth and focus of Premature Ejaculation therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Premature Ejaculation Therapeutic Products under Development, Key Players in Premature Ejaculation Therapeutics, Premature Ejaculation Pipeline Overview, Premature Ejaculation Pipeline, Premature Ejaculation Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Premature Ejaculation Overview
Therapeutics Development
An Overview of Pipeline Products for Premature Ejaculation
Premature Ejaculation Therapeutics under Development by Companies
Premature Ejaculation Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Premature Ejaculation Therapeutics - Products under Development by Companies
Premature Ejaculation Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Premature Ejaculation Therapeutics Development
Johnson & Johnson
Shionogi & Co., Ltd.
GlaxoSmithKline plc
Dong-A Pharmaceutical Co., Ltd.
Futura Medical plc.
Plethora Solutions Holdings plc
Medisyn Technologies, Inc.
NeuroHealing Pharmaceuticals Inc.
Ampio Pharmaceuticals, Inc.
Premature Ejaculation - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
PSD502 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PSD502 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
NH02D - Drug Profile
Product Description
Mechanism of Action
R&D Progress
DA-8031 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
GSK557296 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Escitalopram - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Priligy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PET500 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Clomipramine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Drug For Premature Ejaculation - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zertane - Drug Profile
Product Description
Mechanism of Action
R&D Progress

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=463724&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.